In medical news:

The FDA expanded its warnings against using opioids and benzodiazepines concomitantly. This action is based on new information on three specific opioids—buprenorphine, buprenorphine-naloxone and methadone, which are typically prescribed for the treatment of opioid use disorder—and the risk for respiratory depression when these drugs are used with benzodiazepines or other central nervous system (CNS) depressants.

Read more from Pain Medicine News here.

Leave a Comment

Your email address will not be published. Required fields are marked *